FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 P/E (TTM) :98
ISIN Demat:INE203A01020 Div & Yield %:0.35 EPS (TTM) :92.47
Book Value (RS) :319.6 Market Cap (Rs Cr.):22655.63 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 559.09 408.00 37.03
Other Income 6.17 8.15 -24.29
PBIDT 76.06 60.69 25.33
Interest 0.67 0.34 97.06
PBDT 75.39 60.35 24.92
Depreciation 2.57 9.32 -72.42
PBT 72.82 51.03 42.70
Tax 19.01 14.70 29.32
Deferred Tax -0.41 -2.10 0.00
PAT 54.22 38.43 41.09

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)